PWAM
AVXL icon

Park West Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Park West Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,370,000
Closed -$8.73M – 66
2019
Q4 		$8.73M Buy
3,370,000
+120,000
+4% +$315K 0.37% 59
2019
Q3 		$10.3M Buy
3,250,000
+250,000
+8% +$721K 0.5% 48
2019
Q2 		$10.1M Sell
3,000,000
-495,615
-14% -$1.54M 0.42% 56
2019
Q1 		$10.7M Hold
3,495,615
– – 0.47% 49
2018
Q4 		$5.45M Buy
3,495,615
+53,450
+2% +$121K 0.27% 68
2018
Q3 		$9.4M Buy
3,442,165
+500,000
+17% +$1.41M 0.34% 61
2018
Q2 		$7.71M Sell
2,942,165
-72,200
-2% -$202K 0.29% 72
2018
Q1 		$8.32M Buy
3,014,365
+301,507
+11% +$852K 0.37% 60
2017
Q4 		$8.73M Sell
2,712,858
-160,702
-6% -$632K 0.4% 57
2017
Q3 		$11.9M Sell
2,873,560
-429,267
-13% -$1.91M 0.71% 37
2017
Q2 		$17.6M Buy
3,302,827
+340,737
+12% +$1.97M 0.97% 36
2017
Q1 		$17M Buy
2,962,090
+1,462,090
+97% +$7.55M 0.99% 36
2016
Q4 		$5.94M Buy
+1,500,000
New +$5.34M 0.46% 44

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Park West Asset Management's AVXL Position: Q1 2020 in Review

Park West Asset Management sold out of Anavex Life Sciences (AVXL) in Q1 2020, closing a stake of 3,370,000 shares — an estimated $8.73M sold.

Park West Asset Management first reported a position in AVXL in Q4 2016 and held it in 13 quarters. The position peaked at $17.6M in Q2 2017. 70 funds tracked by Wall St. Rank hold AVXL as of Q1 2020.

  • Park West Asset Management reported no remaining Anavex Life Sciences position as of Q1 2020 after selling out during the quarter.
  • Park West Asset Management sold 3,370,000 Anavex Life Sciences shares in Q1 2020, an estimated $8.73M.
  • Park West Asset Management first reported a position in Anavex Life Sciences in Q4 2016 and held it in 13 quarters.
  • Park West Asset Management's Anavex Life Sciences position peaked at $17.6M in Q2 2017.
  • 70 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2020.

Based on Park West Asset Management's 13F filing for Q1 2020, filed 15 May 2020.